MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
1.700
-0.070
-3.95%
After Hours: 1.750 +0.05 +2.94% 19:29 03/06 EST
OPEN
1.750
PREV CLOSE
1.770
HIGH
1.760
LOW
1.690
VOLUME
464.54K
TURNOVER
--
52 WEEK HIGH
3.840
52 WEEK LOW
1.580
MARKET CAP
54.18M
P/E (TTM)
-0.7321
1D
5D
1M
3M
1Y
5Y
1D
New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
Barchart · 12h ago
VTI ETF Adds $1B in Net Flows — Daily Snapshot, 3/6/26
TipRanks · 1d ago
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
TipRanks · 2d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/5/26
TipRanks · 2d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/4/26
TipRanks · 3d ago
NRX Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 4d ago
NRX Pharmaceuticals Price Target Raised to $45.00/Share From $40.00 by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $45
Benzinga · 4d ago
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.